Mucosolvan Gusto Frutti Di Bosco (Ambroxol Hydrochloride)

Ambroxol increases the production of serous fluid in the respiratory tract, stimulates ciliary activity, and lowers the viscosity of mucus. These actions enhance the mucociliary escalator, allowing mucus to be transported more efficiently toward the throat where it can be expectorated, thereby improving airway clearance.

The dosage of ambroxol hydrochloride is determined by the prescribing healthcare professional based on the patient’s age, weight, clinical condition and local prescribing guidelines. Patients should follow the specific instructions provided by their doctor or pharmacist and not adjust the dose on their own.

Safety data for ambroxol during pregnancy and lactation are limited. The drug should only be used if the potential benefit to the mother outweighs any possible risk to the fetus or infant. Healthcare providers will assess individual circumstances before prescribing it to pregnant or nursing women.

To place an order, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India supplies hospitals, pharmacies and procurement teams worldwide, and will request verification of trade or institutional credentials. The sales team will then respond with pricing, availability, shipping details and any required import documentation.

Both ambroxol and acetylcysteine act as mucolytics, but they have different mechanisms. Ambroxol primarily stimulates serous secretion and ciliary activity, while acetylcysteine breaks disulfide bonds in mucus proteins. Clinical choice often depends on patient tolerance, specific respiratory condition, and physician preference.

Mucosolvan Gusto Frutti Di Bosco should be stored at ambient temperature, preferably below 25 °C. Keep the container tightly closed, protect it from moisture and direct sunlight, and store it in its original packaging to maintain product stability.

The product is an oral liquid taken by mouth. It should be measured with a calibrated dosing device and swallowed. Patients are advised to follow the administration instructions given by their healthcare professional, which may include taking the dose with or without food.

Serious adverse reactions, although rare, include severe allergic responses such as rash, angioedema, or Stevens‑Johnson syndrome, and hepatic dysfunction indicated by elevated liver enzymes. Any signs of a serious reaction require immediate medical attention and discontinuation of the drug.

Patients with known hypersensitivity to ambroxol or any excipients in the formulation should avoid the product. Caution is also advised for individuals with severe renal or hepatic impairment, uncontrolled asthma, or those taking medications that may interact significantly with ambroxol.